We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
GE Healthcare has agreed to supply its FlexFactory manufacturing platform to China-based Xiangxue Pharmaceutical for high-affinity and high-specificity T cell receptor (TCR) cell immunotherapy drugs.